Pharma Net Debt vs Short Term Debt Analysis

0RC6 Stock

75.72 2.97 4.08%

Pharma Mar financial indicator trend analysis is much more than just breaking down Pharma Mar SAU prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pharma Mar SAU is a good investment. Please check the relationship between Pharma Mar Net Debt and its Short Term Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Pharma Mar SAU. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Net Debt vs Short Term Debt

Net Debt vs Short Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pharma Mar SAU Net Debt account and Short Term Debt. At this time, the significance of the direction appears to have strong relationship.

The correlation between Pharma Mar's Net Debt and Short Term Debt is 0.77. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Short Term Debt in the same time period over historical financial statements of Pharma Mar SAU, assuming nothing else is changed. The correlation between historical values of Pharma Mar's Net Debt and Short Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of Pharma Mar SAU are associated (or correlated) with its Short Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Debt has no effect on the direction of Net Debt i.e., Pharma Mar's Net Debt and Short Term Debt go up and down completely randomly.

Correlation Coefficient

0.77

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Short Term Debt

Most indicators from Pharma Mar's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pharma Mar SAU current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Pharma Mar SAU. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Pharma Mar's Selling General Administrative is comparatively stable compared to the past year. Tax Provision is likely to gain to about 10.1 M in 2024, despite the fact that Discontinued Operations is likely to grow to (1.9 M).

	2021	2022	2023	2024 (projected)
Gross Profit	213.4M	182.7M	148.5M	114.0M
Total Revenue	229.8M	196.3M	158.2M	146.3M

Gross Profit Total Revenue

Pharma Mar fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Good Will	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Short Term Investments	Current Deferred Revenue
Total Assets		-0.75	0.81	0.62	0.89	0.35	-0.84	0.68	0.06	0.82	0.16	0.49	0.93	0.08	-0.22	0.34	0.12	0.87	-0.37	0.49	0.99	-0.66	-0.65	0.17	0.57	0.72
Short Long Term Debt Total	-0.75		-0.67	-0.11	-0.79	-0.47	0.91	-0.74	0.04	-0.81	-0.1	-0.25	-0.8	-0.37	0.48	0.05	0.17	-0.87	0.52	0.0	-0.76	0.88	0.74	-0.03	-0.68	-0.59
Other Current Liab	0.81	-0.67		0.6	0.75	-0.03	-0.69	0.82	-0.07	0.57	-0.16	0.38	0.85	-0.25	0.2	0.43	0.16	0.71	-0.65	0.55	0.82	-0.75	-0.68	0.48	0.38	0.83
Total Current Liabilities	0.62	-0.11	0.6		0.34	-0.1	-0.18	0.24	0.1	0.21	0.18	0.4	0.43	-0.51	0.2	0.54	0.57	0.28	-0.12	0.79	0.61	-0.11	-0.11	0.45	-0.09	0.59
Total Stockholder Equity	0.89	-0.79	0.75	0.34		0.46	-0.87	0.73	0.09	0.79	0.11	0.14	0.9	0.25	-0.15	-0.02	0.13	0.88	-0.37	0.12	0.86	-0.67	-0.73	0.25	0.7	0.45
Property Plant And Equipment Net	0.35	-0.47	-0.03	-0.1	0.46		-0.47	0.15	0.36	0.5	0.37	-0.3	0.3	0.78	-0.78	-0.48	0.07	0.44	0.09	-0.39	0.31	-0.27	-0.36	-0.12	0.68	-0.16
Net Debt	-0.84	0.91	-0.69	-0.18	-0.87	-0.47		-0.7	0.02	-0.96	-0.11	-0.28	-0.9	-0.45	0.41	-0.08	0.24	-0.93	0.4	-0.13	-0.83	0.77	0.84	0.1	-0.75	-0.56
Retained Earnings	0.68	-0.74	0.82	0.24	0.73	0.15	-0.7		0.21	0.55	-0.12	0.22	0.74	-0.02	0.03	0.16	0.03	0.75	-0.91	0.21	0.68	-0.91	-0.67	0.35	0.46	0.63
Accounts Payable	0.06	0.04	-0.07	0.1	0.09	0.36	0.02	0.21		-0.02	0.36	-0.21	-0.07	0.21	-0.13	-0.1	0.3	0.01	-0.22	-0.04	0.0	-0.18	0.26	-0.02	0.11	-0.13
Cash	0.82	-0.81	0.57	0.21	0.79	0.5	-0.96	0.55	-0.02		0.21	0.34	0.84	0.5	-0.51	0.15	-0.28	0.9	-0.26	0.19	0.81	-0.65	-0.77	-0.27	0.69	0.5
Non Current Assets Total	0.16	-0.1	-0.16	0.18	0.11	0.37	-0.11	-0.12	0.36	0.21		-0.11	-0.1	0.24	-0.43	-0.28	0.33	0.1	0.23	-0.13	0.04	0.03	0.3	-0.33	-0.08	-0.2
Non Currrent Assets Other	0.49	-0.25	0.38	0.4	0.14	-0.3	-0.28	0.22	-0.21	0.34	-0.11		0.46	-0.21	-0.05	0.82	-0.35	0.27	-0.21	0.75	0.54	-0.28	-0.11	-0.23	0.11	0.76
Cash And Short Term Investments	0.93	-0.8	0.85	0.43	0.9	0.3	-0.9	0.74	-0.07	0.84	-0.1	0.46		0.18	-0.15	0.35	-0.09	0.87	-0.45	0.42	0.94	-0.72	-0.83	0.17	0.73	0.74
Good Will	0.08	-0.37	-0.25	-0.51	0.25	0.78	-0.45	-0.02	0.21	0.5	0.24	-0.21	0.18		-0.73	-0.38	-0.47	0.27	0.19	-0.48	0.05	-0.17	-0.31	-0.58	0.72	-0.25
Common Stock Shares Outstanding	-0.22	0.48	0.2	0.2	-0.15	-0.78	0.41	0.03	-0.13	-0.51	-0.43	-0.05	-0.15	-0.73		0.29	0.26	-0.37	-0.15	0.29	-0.22	0.24	0.2	0.52	-0.44	0.04
Non Current Liabilities Total	0.34	0.05	0.43	0.54	-0.02	-0.48	-0.08	0.16	-0.1	0.15	-0.28	0.82	0.35	-0.38	0.29		-0.22	0.05	-0.23	0.94	0.39	-0.13	-0.09	-0.06	-0.03	0.72
Inventory	0.12	0.17	0.16	0.57	0.13	0.07	0.24	0.03	0.3	-0.28	0.33	-0.35	-0.09	-0.47	0.26	-0.22		-0.09	0.04	0.06	0.07	0.14	0.25	0.71	-0.3	-0.13
Other Current Assets	0.87	-0.87	0.71	0.28	0.88	0.44	-0.93	0.75	0.01	0.9	0.1	0.27	0.87	0.27	-0.37	0.05	-0.09		-0.47	0.14	0.87	-0.76	-0.8	0.04	0.6	0.54
Other Stockholder Equity	-0.37	0.52	-0.65	-0.12	-0.37	0.09	0.4	-0.91	-0.22	-0.26	0.23	-0.21	-0.45	0.19	-0.15	-0.23	0.04	-0.47		-0.21	-0.4	0.82	0.45	-0.33	-0.19	-0.57
Total Liab	0.49	0.0	0.55	0.79	0.12	-0.39	-0.13	0.21	-0.04	0.19	-0.13	0.75	0.42	-0.48	0.29	0.94	0.06	0.14	-0.21		0.52	-0.14	-0.1	0.13	-0.06	0.76
Total Current Assets	0.99	-0.76	0.82	0.61	0.86	0.31	-0.83	0.68	0.0	0.81	0.04	0.54	0.94	0.05	-0.22	0.39	0.07	0.87	-0.4	0.52		-0.67	-0.69	0.19	0.58	0.76
Short Term Debt	-0.66	0.88	-0.75	-0.11	-0.67	-0.27	0.77	-0.91	-0.18	-0.65	0.03	-0.28	-0.72	-0.17	0.24	-0.13	0.14	-0.76	0.82	-0.14	-0.67		0.65	-0.14	-0.53	-0.66
Intangible Assets	-0.65	0.74	-0.68	-0.11	-0.73	-0.36	0.84	-0.67	0.26	-0.77	0.3	-0.11	-0.83	-0.31	0.2	-0.09	0.25	-0.8	0.45	-0.1	-0.69	0.65		-0.15	-0.68	-0.49
Common Stock	0.17	-0.03	0.48	0.45	0.25	-0.12	0.1	0.35	-0.02	-0.27	-0.33	-0.23	0.17	-0.58	0.52	-0.06	0.71	0.04	-0.33	0.13	0.19	-0.14	-0.15		-0.09	0.19
Short Term Investments	0.57	-0.68	0.38	-0.09	0.7	0.68	-0.75	0.46	0.11	0.69	-0.08	0.11	0.73	0.72	-0.44	-0.03	-0.3	0.6	-0.19	-0.06	0.58	-0.53	-0.68	-0.09		0.31
Current Deferred Revenue	0.72	-0.59	0.83	0.59	0.45	-0.16	-0.56	0.63	-0.13	0.5	-0.2	0.76	0.74	-0.25	0.04	0.72	-0.13	0.54	-0.57	0.76	0.76	-0.66	-0.49	0.19	0.31

Click cells to compare fundamentals

Pharma Mar Account Relationship Matchups

Pharma Mar fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	124.7M	330.3M	368.4M	393.3M	341.2M	276.5M
Short Long Term Debt Total	86.1M	56.7M	49.3M	42.6M	43.7M	82.0M
Other Current Liab	12.6M	57.1M	45.4M	55.1M	51.9M	54.5M
Total Current Liabilities	60.4M	94.9M	86.3M	97.3M	95.9M	81.0M
Total Stockholder Equity	11.4M	102.7M	177.9M	223.0M	193.4M	203.1M
Property Plant And Equipment Net	25.8M	25.5M	30.6M	34.7M	47.6M	26.1M
Net Debt	68.5M	(39.5M)	(64.0M)	(107.2M)	(16.4M)	(15.5M)
Retained Earnings	(69.6M)	41.9M	121.3M	156.5M	142.2M	149.3M
Accounts Payable	16.5M	21.0M	26.9M	27.5M	29.2M	28.4M
Cash	17.6M	96.2M	113.3M	149.8M	60.0M	53.4M
Non Current Assets Total	74.7M	84.6M	73.2M	118.1M	88.6M	73.5M
Non Currrent Assets Other	4.8M	100.2M	89.4M	33.5M	1.4M	1.3M
Cash And Short Term Investments	20.9M	195.5M	201.9M	182.4M	162.6M	170.7M
Common Stock Shares Outstanding	18.4M	18.3M	18.1M	18.1M	17.9M	19.8M
Liabilities And Stockholders Equity	124.7M	330.3M	368.4M	393.3M	341.2M	276.5M
Non Current Liabilities Total	56.8M	132.6M	104.1M	73.0M	51.9M	78.1M
Inventory	8.9M	11.9M	10.5M	27.7M	39.3M	22.5M
Other Current Assets	8.6M	14.1M	31.9M	35.7M	23.2M	15.6M
Other Stockholder Equity	69.8M	49.8M	45.6M	55.4M	40.2M	38.2M
Total Liab	117.2M	227.5M	190.5M	170.3M	147.8M	159.1M
Total Current Assets	50.0M	245.7M	295.2M	275.2M	252.6M	175.4M
Short Term Debt	31.3M	16.8M	14.0M	14.7M	14.8M	24.0M
Intangible Assets	6.1M	3.9M	3.2M	2.6M	1.9M	1.8M
Short Term Investments	3.3M	99.3M	88.5M	32.6M	102.5M	107.7M
Current Deferred Revenue	10.1M	52.2M	39.6M	26.1M	25.9M	19.8M
Net Receivables	13.2M	26.7M	78.9M	29.3M	47.8M	44.4M
Other Assets	47.2M	37.9M	33.7M	30.6M	35.1M	40.5M
Accumulated Other Comprehensive Income	12K	15K	14K	38K	19K	14.3K
Other Liab	2.0M	92.7M	68.8M	45.1M	51.8M	40.3M
Net Tangible Assets	10.5M	101.7M	176.8M	221.8M	255.0M	267.8M
Deferred Long Term Liab	5.2M	2.8M	2.1M	1.4M	1.3M	1.2M
Property Plant Equipment	25.6M	24.7M	26.9M	36.9M	42.5M	31.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Pharma Stock Analysis

When running Pharma Mar's price analysis, check to measure Pharma Mar's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma Mar is operating at the current time. Most of Pharma Mar's value examination focuses on studying past and present price action to predict the probability of Pharma Mar's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma Mar's price. Additionally, you may evaluate how the addition of Pharma Mar to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Pharma Net Debt vs Short Term Debt Analysis

Net Debt vs Short Term Debt

Net Debt vs Short Term Debt Correlation Analysis

Correlation Coefficient

Net Debt

Short Term Debt

Pharma Mar fundamental ratios Correlations

Pharma Mar Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Pharma Mar fundamental ratios Accounts

Also Currently Popular

Additional Tools for Pharma Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 0.99	Total Assets
Total Current Assets	+ 0.94	Cash And Short Term Investments
Total Liab	+ 0.94	Non Current Liabilities Total
Cash And Short Term Investments	+ 0.93	Total Assets
Net Debt	+ 0.91	Short Long Term Debt Total
Cash And Short Term Investments	+ 0.9	Total Stockholder Equity

Cash	- 0.96	Net Debt
Other Current Assets	- 0.93	Net Debt
Short Term Debt	- 0.91	Retained Earnings
Other Stockholder Equity	- 0.91	Retained Earnings
Cash And Short Term Investments	- 0.9	Net Debt
Net Debt	- 0.87	Total Stockholder Equity